When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
PLEASE NOTE: In accordance with accreditation criteria, credit will not be awarded for completion of this course beyond 4/30/2018.
Expiration Date: April 30, 2018
Methicillin-resistant Staphylococcus aureus (MRSA) is a multidrug-resistant organism, meaning that it has developed resistance to various antimicrobial agents. It is responsible for many skin infections and, occasionally, severe invasive infectious disease. MRSA is prevalent in U.S. hospitals,
where MRSA infections increase hospital length of stay, costs, and mortality. MRSA has historically been a healthcare-acquired (HA) pathogen but has become more common in community settings as community-acquired (CA) MRSA.
This course describes the background and incidence patterns of
MRSA infections and details the risk factors for both CA- and HA-MRSA. Nurses will learn about the clinical features of MRSA infections, including skin and soft tissue infections, pneumonia, surgical site infection, septicemia, infective arthritis, urinary tract infections, respiratory failure, and ulcers of
the skin. The course also describes diagnostic and treatment methods. Infection prevention and control strategies are discussed at length, including surveillance, environmental decontamination, antibiotic control, isolation, hand hygiene, and decolonization. Nurses will learn about infection prevention guidelines for home care, the importance of staff and patient education, and the healthcare worker’s responsibility for reporting cases to hospital and governmental health departments. This course is appropriate for nurses who have patients affected by MRSA or who work in an environment that may be susceptible to a MRSA outbreak.
- Specify the epidemiology and impact of MRSA.
- Recognize groups at high risk for MRSA infection.
- Identify the clinical features of MRSA.
- Select current treatments for MRSA infections.
- Identify the modes of transmission for MRSA.
- Specify infection prevention strategies to control the spread of MRSA.
Terri Rebmann, PhD, RN, CIC, is an associate professor and Director of the Institute for Biosecurity in the Saint Louis University School of Public Health and Social Justice. She has been with the Institute since its inception in July 2000. She is a PhD nurse researcher with a background in infectious disease emergency preparedness. In addition, she is board certified in infection control and epidemiology. Her work experience includes research and clinical practice with HIV/AIDS patients and hospital infection control. As Director of the Institute for Biosecurity, she is responsible for managing all aspects of the Institute’s MS, MPH, and PhD academic programs, in addition to teaching and doing research. Her research areas of focus include health care and public health professional disaster preparedness and surge capacity issues.
- Contact hours will be awarded for up to one (1) year from date of purchase or through the expiration date indicated above, whichever date comes first.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.